Evidence map›Paper›PMID 40940778›Full record

ReviewCells2025

Attention-Deficit Hyperactivity Disorder (ADHD): A Comprehensive Overview of the Mechanistic Insights from Human Studies to Animal Models.

Matthew William Yacoub, Sophia Rose Smith, Badra Abbas, Fahad Iqbal, Cham Maher Othman Jazieh, Nada Saed Homod Al Shaer, Collin Chill-Fone Luk, Naweed Imam Syed

Abstract readReview
In one paragraph

Review in Cells, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Matthew William YacoubHotchkiss Brain Institute, University of Calgary, Calgary, AB T2N 4N1, Canada.
Sophia Rose SmithO'Brien Office of the Health Sciences, University of Calgary, Calgary, AB T2N 4N1, Canada.
Badra AbbasHotchkiss Brain Institute, University of Calgary, Calgary, AB T2N 4N1, Canada.
Fahad IqbalHotchkiss Brain Institute, University of Calgary, Calgary, AB T2N 4N1, Canada.
Cham Maher Othman JaziehCollege of Medicine, Alfaisal University, Ridah 11533, Saudi Arabia.
Nada Saed Homod Al ShaerCollege of Medicine, Alfaisal University, Ridah 11533, Saudi Arabia.
Collin Chill-Fone LukDepartment of Clinical Neurosciences, University of Calgary, Calgary, AB T2N 4N1, Canada.
Naweed Imam SyedHotchkiss Brain Institute, University of Calgary, Calgary, AB T2N 4N1, Canada.ORCID 0000-0002-6124-9745

Funding

Natural Sciences and Engineering Research Council of Canada #RT690332
6 · The paper itself

Abstract

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental condition marked by persistent inattention, hyperactivity, and impulsivity. Despite its considerable global prevalence, key gaps remain in our understanding of the structural and molecular changes underlying ADHD which complicate adult diagnosis, as symptoms present differently from those observed during childhood ADHD. On the other hand, while psychostimulants effectively mitigate some symptoms, significant controversy surrounds their long-term effects on cognition, learning, and memory, and day-to-day living. Moreover, our understanding of how various medications given to alleviate ADHD symptoms during pregnancy impact the developing fetal brain also remains largely unexplored. Here, we discuss the subtle differences between ADHD in children and adults and how these symptoms alter brain development and maturation. We further examine changes in monoamine signaling in ADHD and how psychostimulant and non-pharmacological treatments modulate these neural networks. We evaluate and discuss findings as they pertain to the long-term use of ADHD medications, including in utero exposure, on cognitive outcomes, and contextualize these findings with mechanistic insights from animal models.

Indexed as

Attention Deficit Disorder with HyperactivityAnimalsBrainCentral Nervous System StimulantsDisease Models, AnimalFemaleHumansPregnancyPrenatal Exposure Delayed EffectsCentral Nervous System Stimulantsanimal modelsattention-deficit/hyperactivity disordercognitive outcomesin utero exposuremonoamine signalingneurodevelopmentpsychostimulants

Identifiers

PMID40940778
PMCPMC12428297

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.